Schizophrenia
900 results
201 - 300
Switching antipsychotics versus continued current treatment in people with non‐responsive schizophrenia- Antipsychotic dose reduction compared to dose continuation for people with schizophrenia
- Yoga as part of a package of care versus standard care for schizophrenia
- Fluphenazine decanoate (depot) and enanthate for schizophrenia: Cochrane systematic review
- Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia: Cochrane systematic review
- Beta-blocker supplementation of standard drug treatment for schizophrenia: Cochrane systematic review
- Clozapine combined with different antipsychotic drugs for treatment‐resistant schizophrenia
- Antipsychotic switching for people with schizophrenia who have neuroleptic‐induced weight or metabolic problems
- Voxel‐based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis
- Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia: Cochrane systematic review
- Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia
Training of patients with schizophrenia to recognize the early signs of recurrence - Information and communication technology in patient education and support for people with schizophrenia
- Anticholinergic medication for non-clozapine neuroleptic-induced hypersalivation in people with schizophrenia: Cochrane systematic review
Maintenance treatment with varenicline improves smoking cessation in patients with schizophrenia and bipolar disorder- Newer atypical antipsychotic medication versus clozapine for schizophrenia: Cochrane systematic review
- Tai Chi plus standard care versus other exercise plus standard care for people with schizophrenia or related disorders
- Computer‐based Cognitive Remediation Therapy plus standard care versus standard care for people with schizophrenia or related disorders
- Risperidone vs. other atypical antipsychotic medication for schizophrenia
- Cognitive behavioural therapy plus standard care versus standard care for persistent aggressive behaviour or agitation in people with schizophrenia
- Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia
- Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders: Cochrane systematic review
- Chlorpromazine versus atypical antipsychotic drugs for schizophrenia
- Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses
- Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders: Cochrane systematic review
- Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia
- Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems
- Cognitive behavioural therapy plus standard care vs. standard care or other psychosocial therapies for people with schizophrenia
- Schizophrenia
- Music therapy for schizophrenia or schizophrenia-like illnesses
- Art therapy for schizophrenia or schizophrenia‐like illnesses
- Levomepromazine for schizophrenia
- Drama therapy for schizophrenia or schizophrenia-like illnesses: Cochrane systematic review
- Nicotine for schizophrenia
- Music therapy for people with schizophrenia and schizophrenia‐like disorders
- Aripiprazole for schizophrenia
- Perphenazine for schizophrenia
- Amisulpride for schizophrenia
- Penfluridol for schizophrenia
- Quetiapine for schizophrenia
- Trifluoperazine for schizophrenia
- Carbamazepine for schizophrenia
- Quetiapine for schizophrenia
- Perazine for schizophrenia
- Valproate for schizophrenia
- Lithium for schizophrenia
- Carbamazepine for schizophrenia
- Lithium for schizophrenia
- Thioridazine for schizophrenia
- Estrogen for schizophrenia
- Perphenazine for schizophrenia
- Aripiprazole for schizophrenia
- Cannabis and schizophrenia
- Trifluoperazine for schizophrenia
- Benperidol for schizophrenia
- Glutamatergic drugs for schizophrenia
- Loxapine for schizophrenia
- Hypnosis for schizophrenia
- Zotepine for schizophrenia
- Perazine for schizophrenia
- Pericyazine for schizophrenia
- Valproate for schizophrenia
- Clozapine dose for schizophrenia
- Zuclopenthixol dihydrochloride for schizophrenia
- Acetylcholinesterase inhibitors for schizophrenia
- Morita therapy for schizophrenia
- Sulpiride augmentation for schizophrenia
- Depot risperidone for schizophrenia
- First rank symptoms for schizophrenia
- Psychoeducation for schizophrenia
- Horticultural therapy for schizophrenia
- Family interventions in schizophrenia
- Distraction techniques for schizophrenia
- Family intervention for schizophrenia
- Acetylcholinesterase inhibitors for schizophrenia
- Monetary incentives for schizophrenia
- Risperidone versus olanzapine for schizophrenia
- Chlorpromazine versus penfluridol for schizophrenia
- Depot fluspirilene for schizophrenia
- Depot haloperidol decanoate for schizophrenia
- Chinese herbal medicine for schizophrenia